Methods
Cumulative, prospective, registry study of 181 men (mean age: 59.11 ± 6.06 years) with testosterone levels below 12.1 nmol/L and a body mass index (BMI) of ≥30 kg/m2. All men received parenteral testosterone undecanoate 1000 mg/12 weeks following an initial 6-week interval. 89 men were treated five years, 114 four years, 133 three years, 159 two years, 181 one year. The changing numbers do not reflect drop-out rates but are a result of the design as new patients are added once they have received at least one year of treatment.
